Journal
INFECTION AND IMMUNITY
Volume 69, Issue 2, Pages 906-911Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.69.2.906-911.2001
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI22532-13] Funding Source: Medline
Ask authors/readers for more resources
To determine the role of endogenous migration-inhibitory factor (MIF) in the development of protective immunity against cutaneous leishmaniasis, we analyzed the course of cutaneous Leishmania major infection in MIF gene deficient mice (MIF-/-) and wild-type (MIF+/+) mice. Following cutaneous L. major infection, MIF-/- mice were susceptible to disease and developed significantly larger lesions and greater parasite burdens than MIF+/+ mice, Interestingly, antigen-stimulated lymph node cells from MIF-/- mice produced more interleukin-4 (IL-4) and gamma interferon (IFN-gamma) than those from MIF+/+ mice, although the differences were statistically not significant. IFN-gamma -activated resting peritoneal macrophages front MIF-/- mice showed impaired macrophage leishmanicidal activity and produced significantly lower levels of nitric oxide and superoxide in vitro. The macrophages from MIF-/- mice, however, produced much more IL-6 than macrophages from wild-type mice. These findings demonstrate that endogenous MIF plays an important role in the development of protective immunity against L. major in vivo. Furthermore, they indicate that the susceptibility of MIF-/- mice to L, major infection is due to impaired macrophage leishmanicidal activity rather than dysregulation of Th1 and Th2 responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available